Perclot
Payments companies reported to CMS as associated with Perclot. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Perclot, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Perclot
These are the largest totals companies reported as associated with Perclot. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Gerald Feuer | Atlanta, GA | Gynecologic Oncology | $22,250.38 |
| Amit Agarwal | Sugar Land, TX | Colon & Rectal Surgery | $6,395.38 |
| Eric Smith | Ashland, KY | Surgery | $4,150.91 |
| Stacey South | Sarasota, FL | Gynecologic Oncology | $3,802.50 |
| Allen Chudzinski | Tampa, FL | Colon & Rectal Surgery | $3,067.08 |
| Ceana Nezhat | Atlanta, GA | Gynecology | $1,558.61 |
| Rachael Piver | Columbus, OH | Obstetrics & Gynecology | $1,233.83 |
| Gini Ikwuezunma | Oklahoma City, OK | Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) | $985.54 |
| Sarin Soyemi | Saint Louis, MO | Obstetrics & Gynecology | $917.51 |
| Sarah Swartz | Washington, DC | Obstetrics & Gynecology | $912.98 |
Prescribed Perclot?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.